Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection

Anesthesiology

Volumn 112, Issue 5, 2010, Pages 1136-1145

  Tsutsumi, Yasuo M ^a   Kawaraguchi, Yoshitaka ^b,c   Horikawa, Yousuke T ^b,c   Niesman, Ingrid R ^b,c   Kidd, Michael W ^b,c   Chin Lee, Blake ^b,c   Head, Brian P ^b,c   Patel, Piyush M ^b,c   Roth, David M ^b,c   Patel, Hemal H ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b University of California   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 3; GLUCOSE TRANSPORTER 4; ISOFLURANE; OXYGEN;

ANESTHETIC RECOVERY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPERFUSION INJURY; SUCROSE DENSITY GRADIENT CENTRIFUGATION; TREATMENT OUTCOME; WILD TYPE;

EID: 77951693552     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181d3d624     Document Type: Article

References (55)

1. ATP channels: Reduction of myocardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87: 361-370
2. Cason BA, Gamperl AK, Slocum RE, Hickey RF: Anesthetic-induced preconditioning: Previous administration of isoflurane decreases myocardial infarct size in rabbits. ANESTHESIOLOGY 1997; 87:1182-1190
3. Tonkovic-Capin M, Gross GJ, Bosnjak ZJ, Tweddell JS, Fitzpatrick CM, Baker JE: Delayed cardioprotection by isoflurane: Role of K(ATP) channels. Am J Physiol Heart Circ Physiol 2002; 283:H61-8
4. Amour J, Brzezinska AK, Weihrauch D, Billstrom AR, Zielonka J, Krolikowski JG, Bienengraeber MW, Warltier DC, Pratt PF Jr, Kersten JR: Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning. ANESTHESIOLOGY 2009; 110:317-325
5. Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR, Pagel PS, Warltier DC: Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: Role of cyclooxygenase-2. ANESTHESIOLOGY 2004; 100:525-531
6. Chiari PC, Bienengraeber MW, Weihrauch D, Krolikowski JG, Kersten JR, Warltier DC, Pagel PS: Role of endothelial nitric oxide synthase as a trigger and mediator of isoflu-rane-induced delayed preconditioning in rabbit myocardium. ANESTHESIOLOGY 2005; 103:74-83
7. Tsutsumi YM, Patel HH, Huang D, Roth DM: Role of 12-lipoxygenase in volatile anesthetic-induced delayed preconditioning in mice. Am J Physiol Heart Circ Physiol 2006; 291:H979-83
8. Feng J, Lucchinetti E, Fischer G, Zhu M, Zaugg K, Schaub MC, Zaugg M: Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning: Role of HIF1a and CREB. Cardiovasc Res 2008; 78:98-107
9. Weber NC, Schlack W: Inhalational anaesthetics and cardioprotection. Handb Exp Pharmacol 2008; 182:187-207
10. Patel HH, Murray F, Insel PA: Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol 2008; 48:359-391
11. Williams TM, Lisanti MP: The caveolin proteins. Genome Biol 2004; 5:214
12. Stan RV: Structure of caveolae. Biochim Biophys Acta 2005; 1746:334-348
13. Chun M, Liyanage UK, Lisanti MP, Lodish HF: Signal transduction of a G protein-coupled receptor in caveolae: Co-localization of endothelin and its receptor with caveolin. Proc Natl Acad Sci USA 1994; 91:11728-11732
14. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, Lisanti MP: Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 1998; 428:205-211
15. Feron O, Dessy C, Opel DJ, Arstall MA, Kelly RA, Michel T: Modulation of the endothelial nitric-oxide synthase-caveo-lin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J Biol Chem 1998; 273:30249-30254
16. Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers MG Jr, Ishikawa Y: Caveolin is an activator of insulin receptor signaling. J Biol Chem 1998; 273:26962-26968
17. Rybin VO, Xu X, Lisanti MP, Steinberg SF: Differential targeting of beta-adrenergic receptor subtypes and adeny-lyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 2000; 275:41447-41457
18. Patel HH, Tsutsumi YM, Head BP, Niesman IR, Jennings M, Horikawa Y, Huang D, Moreno AL, Patel PM, Insel PA, Roth DM: Mechanisms of cardiac protection from ischemia/reperfusion injury: A role for caveolae and caveolin-1. FASEB J 2007; 21:1565-1574
19. Horikawa YT, Patel HH, Tsutsumi YM, Jennings MM, Kidd MW, Hagiwara Y, Ishikawa Y, Insel PA, Roth DM: Caveo-lin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury. J Mol Cell Cardiol 2008; 44:123-130
20. Tsutsumi YM, Horikawa YT, Jennings MM, Kidd MW, Niesman IR, Yokoyama U, Head BP, Hagiwara Y, Ishikawa Y
21. Miyanohara A, Patel PM, Insel PA, Patel HH, Roth DM: Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning. Circulation 2008; 118:1979-1988
22. Nishino Y, Miura T, Miki T, Sakamoto J, Nakamura Y, Ikeda Y, Kobayashi H, Shimamoto K: Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. Cardiovasc Res 2004; 61:610-619
23. Hagiwara Y, Sasaoka T, Araishi K, Imamura M, Yorifuji H, Nonaka I, Ozawa E, Kikuchi T: Caveolin-3 deficiency causes muscle degeneration in mice. Hum Mol Genet 2000; 9:3047-3054
24. Deady JE, Koblin DD, Eger EI II, Heavner JE, D'Aoust B: Anesthetic potencies and the unitary theory of narcosis. Anesth Analg 1981; 60:380-384
25. Tsutsumi YM, Yokoyama T, Horikawa Y, Roth DM, Patel HH: Reactive oxygen species trigger ischemic and pharmacological postconditioning: In vivo and in vitro characterization. Life Sci 2007; 81:1223-1227
26. Tsutsumi YM, Patel HH, Lai NC, Takahashi T, Head BP, Roth DM: Isoflurane produces sustained cardiac protection after ischemia-reperfusion injury in mice. ANESTHESIOL-OGY 2006; 104:495-502
27. Patel HH, Head BP, Petersen HN, Niesman IR, Huang D, Gross GJ, Insel PA, Roth DM: Protection of adult rat cardiac myocytes from ischemic cell death: Role of caveolar microdomains and delta-opioid receptors. Am J Physiol Heart Circ Physiol 2006; 291:H344-50
28. Guo Y, Bao W, Wu WJ, Shinmura K, Tang XL, Bolli R: Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice. Basic Res Cardiol 2000; 95:479-484
29. Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Takano H, Bhatnagar A, Bolli R: Cyclooxygenase-2 mediates the car-dioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 2000; 97:10197-10202
30. Patel HH, Fryer RM, Gross ER, Bundey RA, Hsu AK, Isbell M, Eusebi LO, Jensen RV, Gullans SR, Insel PA, Nithipa-tikom K, Gross GJ: 12-lipoxygenase in opioid-induced delayed cardioprotection: Gene array, mass spectrometric, and pharmacological analyses. Circ Res 2003; 92:676-682
31. Baxter GF, Goma FM, Yellon DM: Characterisation of the infarct-limiting effect of delayed preconditioning: Time course and dose-dependency studies in rabbit myocardium. Basic Res Cardiol 1997; 92:159-167
32. Hu G, Schwartz DE, Shajahan AN, Visintine DJ, Salem MR, Crystal GJ, Albrecht RF, Vogel SM, Minshall RD: Isoflurane, but not sevoflurane, increases transendothelial albumin permeability in the isolated rat lung: Role for enhanced phosphorylation of caveolin-1. ANESTHESIOLOGY 2006; 104: 777-785
33. Cao H, Sanguinetti AR, Mastick CC: Oxidative stress activates both Src-kinases and their negative regulator Csk and induces phosphorylation of two targeting proteins for Csk: Caveolin-1 and paxillin. Exp Cell Res 2004; 294:159-171
34. Yamada E: The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol 1955; 1:445-458
35. Anderson RG: Potocytosis of small molecules and ions by caveolae. Trends Cell Biol 1993; 3:69-72
36. Fujimoto T: Calcium pump of the plasma membrane is localized in caveolae. J Cell Biol 1993; 120:1147-1157
37. Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV, Simons K: VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 1995; 92:10339-10343
38. Banfi C, Brioschi M, Wait R, Begum S, Gianazza E, Fratto P, Polvani G, Vitali E, Parolari A, Mussoni L, Tremoli E: Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts. Proteom-ics 2006; 6:1976-1988
39. Durr E, Yu J, Krasinska KM, Carver LA, Yates JR, Testa JE, Oh P, Schnitzer JE: Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol 2004; 22:985-992
40. Foster LJ, De Hoog CL, Mann M: Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA 2003; 100:5813-5818
41. McMahon KA, Zhu M, Kwon SW, Liu P, Zhao Y, Anderson RG: Detergent-free caveolae proteome suggests an interaction with ER and mitochondria. Proteomics 2006; 6:143-152
42. Mishra S, Joshi PG: Lipid raft heterogeneity: An enigma. J Neurochem 2007; 103(suppl 1):135-142
43. Patra SK: Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 2008; 1785:182-206
44. Koneru S, Penumathsa SV, Thirunavukkarasu M, Samuel SM, Zhan L, Han Z, Maulik G, Das DK, Maulik N: Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4. Am J Physiol Heart Circ Physiol 2007; 292:H2060-72
45. Lira VA, Soltow QA, Long JHD, Betters JL, Sellman JE, Criswell DS: Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle. Am J Physiol Endocrinol Metab 2007; 293:E1062-8
46. Li J, Hu X, Selvakumar P, Russell RR III, Cushman SW, Holman GD, Young LH: Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Am J Physiol Endocrinol Metab 2004; 287:E834-41
47. Nugent C, Prins JB, Whitehead JP, Wentworth JM, Chat-terjee VK, O'Rahilly S: Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma. J Biol Chem 2001; 276:9149-9157
48. Long SD, Pekala PH: Regulation of GLUT4 gene expression by arachidonic acid. Evidence for multiple pathways, one of which requires oxidation to prostaglandin E2. J Biol Chem 1996; 271:1138-1144
49. Dransfeld O, Rakatzi I, Sasson S, Gruzman A, Schmitt M, Haussinger D, Eckel J: Eicosanoids participate in the regulation of cardiac glucose transport by contribution to a rearrangement of actin cytoskeletal elements. Biochem J 2001; 359:47-54
50. Head BP, Patel HH, Roth DM, Murray F, Swaney JS, Nies-man IR, Farquhar MG, Insel PA: Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J Biol Chem 2006; 281:26391-26399
51. Ismaeil MS, Tkachenko I, Gamperl AK, Hickey RF, Cason BA: Mechanisms of isoflurane-induced myocardial preconditioning in rabbits. ANESTHESIOLOGY 1999; 90:812-821
52. Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, Schubert W, Williams TM, Brasaemle DL, Jelicks LA, Scherer PE, Kim JK, Lisanti MP: Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am J Physiol Cell Physiol 2005; 288: C1317-31
53. Oshikawa J, Otsu K, Toya Y, Tsunematsu T, Hankins R, Kawabe J, Minamisawa S, Umemura S, Hagiwara Y, Ish-ikawa Y: Insulin resistance in skeletal muscles of caveolin-3-null mice. Proc Natl Acad Sci USA 2004; 101:12670-12675
54. Woodman SE, Park DS, Cohen AW, Cheung M, Chandra M, Shirani J, Tang B, Jelicks LA, Kitsis RN, Christ GJ, Factor SM, Tanowitz HB, Lisanti MP: Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperac-tivation of the p42/44 MAP kinase cascade. J Biol Chem 2002; 277:38988-38997
55. Augustus AS, Buchanan J, Addya S, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP: Substrate uptake and metabolism are preserved in hyper-trophic caveolin-3 knockout hearts. Am J Physiol Heart Circ Physiol 2008; 295:H657-66